Tag: Access

  • WhatsApp bug causing some Android devices to falsely report microphone access

    WhatsApp bug causing some Android devices to falsely report microphone access

    [ad_1]

    San Francisco: Meta-owned WhatsApp and Google have acknowledged a bug that seems to be allowing WhatsApp to access phones’ microphones unnecessarily on some Android devices.

    The issue first surfaced a month ago, but it received renewed attention after a Twitter engineer mentioned it in a post boosted by Elon Musk, reports Engadget.

    Twitter engineer Foad Dabiri recently shared an image that raised concerns about the app’s privacy practices. The image appeared to show that the app’s microphone was continuously running in the background, even when not in use.

    MS Education Academy

    Dabiri tweeted a screenshot from the Privacy Dashboard on his Android device, which revealed how frequently the app accessed his microphone and camera.

    “WhatsApp has been using the microphone in the background, while I was asleep and since I woke up at 6 a.m. (and that’s just a part of the timeline!) What’s going on?,” he tweeted.

    Later, Musk retweeted Dabiri’s post, saying “WhatsApp cannot be trusted”.

    According to a statement shared on Twitter by WhatsApp, the problem was caused by an Android-related issue rather than inappropriate microphone access by the messaging app.

    “We believe this is a bug on Android that mis-attributes information in their Privacy Dashboard and have asked Google to investigate and remediate,” the company said.

    Subscribe us on The Siasat Daily - Google News

    [ad_2]
    #WhatsApp #bug #causing #Android #devices #falsely #report #microphone #access

    ( With inputs from www.siasat.com )

  • OpenAI restores access to ChatGPT in Italy after ban

    OpenAI restores access to ChatGPT in Italy after ban

    [ad_1]

    San Francisco: OpenAI has restored access to the ChatGPT service in Italy, after the country banned the AI chatbot in response to an order from the local data protection authority over user data concerns.

    Microsoft-backed OpenAI had “addressed or clarified” the issues raised by the Italian Data Protection Authority (or GPDP) in late March, reports The Verge.

    “ChatGPT is available again to our users in Italy. We are excited to welcome them back, and we remain dedicated to protecting their privacy,” the company said in a statement.

    MS Education Academy

    EU users can submit a new form to remove personal data under Europe’s General Data Protection Regulation (GDPR). A new tool will also verify users’ ages upon signup in Italy.

    Earlier this month, OpenAI blocked access to its AI chatbot ChatGPT in Italy.

    “We regret to inform you that we have disabled ChatGPT for users in Italy at the request of the Italian Garante,” OpenAI had said in a letter.

    In the order, the Italian regulator Garante said it’s concerned that the ChatGPT maker is breaching the EU GDPR, claiming that OpenAI has unlawfully processed the data of Italian citizens.

    “There is no way ChatGPT can continue to process data in breach of privacy laws. The Italian SA has imposed an immediate temporary limitation on the processing of Italian users’ data by OpenAI, the US-based company developing and managing the platform. An inquiry into the facts of the case was initiated as well,” the regulator noted.

    Moreover, the company also said to refund the amount to all users in Italy who purchased a ChatGPT Plus subscription in March.

    OpenAI, late last month admitted that some users’ payment information may have been exposed when it took ChatGPT offline owing to a bug.

    The company took ChatGPT offline due to a bug in an open-source library which allowed some users to see titles from another active user’s chat history, according to OpenAI.

    [ad_2]
    #OpenAI #restores #access #ChatGPT #Italy #ban

    ( With inputs from www.siasat.com )

  • More adults think access to abortion should be easier, Pew report finds

    More adults think access to abortion should be easier, Pew report finds

    [ad_1]

    The number of adults living in states where abortion is banned or restricted who believe that access to abortion should be easier has grown since 2019, according to a new report from the Pew Research Center.

    In states that implemented bans on nearly all abortions after the Dobbs decision last year, 43 percent of adults said they believe it should be easier to get an abortion where they live, compared to 31 percent in 2019. In states that have seen new restrictions, either implemented or tied up in legal disputes, 38 percent believe access should be easier, up from 27 percent in 2019. The numbers are also up in states without any new abortion restrictions, now at 27 percent compared to 24 percent in 2019.

    The report, released Wednesday, included data from 5,079 respondents with a margin of error of +/- 1.7 percentage points. The survey was conducted between March 27 and April 2.

    [ad_2]
    #adults #access #abortion #easier #Pew #report #finds
    ( With inputs from : www.politico.com )

  • Health care access for trans youth is crumbling — and not just in red states

    Health care access for trans youth is crumbling — and not just in red states

    [ad_1]

    aptopix anti transgender healthcare bills missouri 77689

    The impact of gender-affirming care bans — inflamed by the rhetoric on the right about “child grooming” — is rippling beyond Republican-controlled states, making it harder everywhere for transgender youth to receive care and physicians to provide it, eight doctors who provide gender-affirming care to transgender youth told POLITICO. The Human Rights Campaign and the Southern Poverty Law Center, which have been tracking attacks against doctors, report similar findings.

    Even in states without bans, providers said death threats, harassment, fears of litigation and, in some cases, a lack of support from institutions have created a chilling effect that undermines their ability to provide care.

    “I got an email telling me that I’m evil, I’m foolish, my work is opposing God, that I harm children, that I’m going to hell, and that I should die,” said Meredithe McNamara, an assistant professor of pediatrics who specializes in adolescent medicine at Yale University. “The threats, the harassment, the constant fear of, ‘Did I say that right? Is that OK? Should I have said that differently? Did I present my position in a public space as effectively as possible, and also did I say anything that is going to get my family targeted in some way?’”

    Physicians in states where gender-affirming care remains legal said they now spend significant chunks of patient visits either batting down misinformation from parents or talking through kids’ mental health concerns related to the new laws. The bans outlawing therapies in nearly a third of the country threaten to overwhelm clinics in blue states, like Minnesota, that already have waiting lists of anywhere from several months to more than a year and have left red-state providers grappling with how to care for their young transgender patients under the bans.

    “We think about this affecting kids who live in [ban] states, but it’s affecting kids everywhere and it’s affecting care everywhere,” said Angela Kade Goepferd, medical director of the Gender Health Program at Children’s Minnesota. “It affects the families in the states where care is banned, and it affects the families in the states where the care is not.”’

    And the bans keep coming: North Dakota Gov. Doug Burgum on Wednesday signed a law banning gender-affirming care for transgender youth. Nebraska lawmakers are poised to enact a similar ban after legislation passed a second round of debate earlier this month. Missouri Attorney General Andrew Bailey’s emergency regulation requiring transgender youth and adults complete a long checklist before receiving gender-affirming care is scheduled to take effect this week. And Montana Gov. Greg Gianforte is expected to soon sign a ban after legislators adopted his proposed amendments last week over the pleas of their transgender colleague.

    “I’ve sat down and met with transgender youth and adults. I understand their struggles are real, and my heart goes out to them. I firmly believe that, as with all of God’s children, Montanans who struggle with their gender identity deserve love, compassion, and respect,” Gianforte wrote in a letter to Montana’s Republican legislative leadership last week. But, he argued, it is “right and appropriate” to restrict access to hormones and surgery to adults.

    Gianforte and other conservatives argue that kids aren’t mature enough to make serious, life-altering medical decisions, even with parental consent, and have expressed concerns about the long-term outcomes of such interventions.

    While some doctors, especially those early in their careers, said the bans have inspired them to work harder and continue providing this kind of care, others who are older said they have considered quitting or retiring early — though they acknowledge doing so would make it even harder for their patients to receive care. There are an estimated 300,000 transgender youth in the U.S. and about 60 comprehensive gender clinics for children and adolescents, though care can also be provided outside of those settings, according to the Human Rights Campaign and the Williams Institute, a think tank that researches sexual orientation and gender identity law at the UCLA School of Law.

    The pediatricians told POLITICO that part of their ethos is being an advocate for children, but the threats have left them worried about their personal safety, and the safety of their families, patients and hospitals. Four of the doctors interviewed were granted anonymity because of fears about threats to their safety, their clinic, their patients or their own family, or because they were not authorized to speak by their institution, in some cases because of the threats.

    But some of the doctors said they feel that by staying quiet they are protecting their institution’s safety but letting down their patients.

    “I know many of my colleagues feel like when we’re doing what they need us to do for our protection and our institution’s protection, many of us also feel like we’re letting the community who needs us the most down,” a blue state pediatrician said.

    Those willing to speak on the record said they were doing so either because they had no family, had talked through the possible risks with their spouses and children, or because they felt protected and supported to speak publicly by their hospital or clinic.

    “As our legislature also votes to advance constitutional carry, and as AR-15s are incredibly easy to get, there’s a non-zero chance somebody might kill me, and I know that. I don’t like it. At least I would die standing up for my values, but I’ve had to make peace with that,” said Alex Dworak, associate medical director of family medicine at OneWorld and assistant professor of family medicine at University of Nebraska Medical Center.

    Targeting physicians is not new: The ’70s and ’80s saw a wave of attacks against abortion clinics, including 110 cases of arson, firebombing or bombing. Three people were killed inside a Colorado Planned Parenthood in 2015. And just last year, an under-construction abortion clinic in Casper, Wyo. was set on fire.

    While Arkansas was the first state to enact a gender-affirming care ban in 2021 — after the legislature overrode then-Republican Gov. Asa Hutchinson’s veto — doctors told POLITICO that the threats didn’t begin in earnest until the following year when Boston Children’s was targeted on social media and received several bomb threats over the summer and fall.

    In 2023, those threats have continued as more red states approve bans as part of a broader agenda that includes preventing transgender people from participating in sports or using bathrooms in accordance with their gender identity and restricting access to drag shows.

    According to the Southern Poverty Law Center, which tracks hate speech, 24 hospitals and clinics that provide gender-affirming care to transgender youth have been targeted on social media over the last year, resulting in bomb threats, death threats to medical staff and temporary suspensions of services. And the Human Rights Campaign said the attacks have steadily increased.

    “We launched our gender health program at Children’s Minnesota in 2019 — the front page of our Star Tribune here in Minneapolis — and barely a peep,” Goepferd said. “We have really been, up until recently, able to provide good, high-quality care in a way that we would all want to, regardless of what speciality in pediatrics we were in.”

    Every major medical association, including the American Medical Association, the American Academy of Pediatrics and the American Psychological Association, supports the use of gender-affirming care to treat transgender people with gender dysphoria, or the feelings of discomfort or distress some transgender people experience when their bodies don’t align with their gender identity. For transgender youth, that typically includes social support, mental health help, puberty blockers, hormone therapy and, very rarely, gender-affirming surgery.

    Those who oppose gender-affirming care argue that kids should wait until they are adults to make the decision to take hormones or undergo surgery, and that the science around such treatments is unsettled.

    “Children suffering discomfort with their sex are best served by compassionate mental health care that enables them to live comfortably in their bodies and with their true identities as male or female,” Matt Sharp, senior counsel and director of the Center for Legislative Advocacy at the conservative legal powerhouse Alliance Defending Freedom, which has helped conservative lawmakers draft trans-focused bills, said in a statement. He added that the organization will “continue to protect children from harmful, irreversible, and unnecessary medical procedures.”

    The American Medical Association, the American Academy of Pediatrics and the American Psychological Association have released statements, published op-eds and documents in support of gender-affirming care and provided coaching and technical assistance to state-level affiliates that they say are closer to the legislative process and better suited to testifying at hearings. But several providers said they need more support.

    “Right now, individual providers show up in public spaces and we feel like we get seen as lone actors, and that we don’t have the backing of large credible institutions, and that’s a really scary reality,” McNamara said. “It’s no longer like, so-and-so who speaks for the American Medical Association says this. It’s this person who you’ve never heard of is here — and it makes us much easier to target.”

    Jack Resneck Jr., president of the American Medical Association, said that the association “stands in vehement opposition to governmental attempts to criminalize or otherwise impede on clinical decision-making.” Resneck added that the AMA has worked with state medical associations to oppose gender-affirming care bans since legislation first emerged in 2020 and has also been involved in legal challenges.

    Mark Del Monte, the American Academy of Pediatrics’ chief executive officer and executive vice president, called gender-affirming care “vital to the health and wellbeing of our gender-diverse patients.”

    Doctors in blue states also said they are happy to see legislatures enact so-called shield laws protecting access to gender-affirming care — as California, Colorado, Illinois, Massachusetts, New Mexico and Washington have done — but some worry those policies will not hold up in court.

    These doctors said they’re also worried about whether they will have the capacity to provide care to out-of-state patients given that most have waitlists that are several months long.

    “It makes me worried about how we can adequately meet the needs of patients and families both here in Washington who have been on our waiting list for many months, but also so many patients and families that are uprooting their lives to be able to continue care,” said Gina Sequeira, co-director of Seattle Children’s Gender Clinic.

    Broadly, the doctors worry about the future practice of gender-affirming care. They say that not only is the chilling effect from the bans stymieing research and collaboration, but also they fear that it will dissuade future doctors from going into an already small field and prevent doctors from receiving training.

    “I am hopeful that I can be a quiet country doc and not have this be a part of my life. That is my hope, that this is not forever,” a red state pediatrician said. “But it’s hard to see that. It’s hard to see that future.”

    [ad_2]
    #Health #care #access #trans #youth #crumbling #red #states
    ( With inputs from : www.politico.com )

  • Alito extends reprieve for abortion pill access, maintaining status quo for 2 more days

    Alito extends reprieve for abortion pill access, maintaining status quo for 2 more days

    [ad_1]

    supreme court abortion pill 01288

    The justices are mulling whether a ruling from the 5th Circuit Court of Appeals should go into effect or whether it should be blocked while further appeals proceed.

    If allowed to take effect, the 5th Circuit’s April 12 ruling would suspend various policies the FDA has enacted since 2016 to make mifepristone more accessible — including telemedicine prescription, mail delivery, retail pharmacy dispensing and the approval of a generic version of the drug. The ruling also would scale back the approved “on label” use of the drug from 10 weeks of pregnancy to seven weeks — before many patients know they are pregnant.

    The appeals court suggested its ruling was a middle-ground approach because it did not go along with a Texas federal judge’s order to suspend mifepristone’s registration altogether.

    However, the FDA and the two drug companies that make mifepristone told the Supreme Court that the 5th Circuit’s ruling could amount to a nationwide ban of the drug because of lengthy delays in returning to labeling and protocols that have not been required for years.

    Anti-abortion medical groups that are challenging the drug disputed that characterization, saying the ruling would reimpose important safety restrictions on the drug.

    Alito acted single-handedly because he oversees emergency appeals from the 5th Circuit. It is not a clear signal about how Alito or the other justices will ultimately vote on whether to allow the 5th Circuit’s ruling to go into effect.

    [ad_2]
    #Alito #extends #reprieve #abortion #pill #access #maintaining #status #quo #days
    ( With inputs from : www.politico.com )

  • Abortion pill maker sues FDA to preserve access

    Abortion pill maker sues FDA to preserve access

    [ad_1]

    wr abortionpills

    A ruling by the 5th Circuit Court of Appeals now pending before the Supreme Court would unwind policies the FDA has approved since 2016 to make the abortion pill more accessible — including telemedicine prescription, mail delivery and retail pharmacy dispensing — and shrink the window of time patients are approved by FDA to take the drug from 10 to seven weeks of gestation — before many know they are pregnant.

    The 5th Circuit’s decision, which endorses much of a challenge brought by the anti-abortion medical group Alliance for Hippocratic Medicine, would also suspend the FDA’s 2019 approval of the generic version of mifepristone made by GenBioPro.

    “If the AHM Fifth Circuit Order goes into effect, the result will be chaos,” GenBioPro warned in its suit. “No court in history has ever ‘stayed’ or ‘suspended’ a longstanding FDA approval, and FDA has no template for responding to — or implementing — those decisions.”

    The FDA declined to comment on the litigation.

    Making similar arguments to the company’s, some Democratic lawmakers and activists have recently demanded that the Biden administration ignore a potential court order suspending approval of the pill or direct the FDA to use enforcement discretion to keep the pill on the market.

    GenBioPro claims that, before suing, it repeatedly approached the FDA to ask what the process would be for suspending approval and what rights the company has under that scenario and received no response.

    “Notwithstanding the exigent circumstances and the numerous tools available to FDA, FDA has repeatedly refused to assure GenBioPro or the public that it will afford GenBioPro adequate procedures before suspending GenBioPro’s … approval,” the company wrote.

    [ad_2]
    #Abortion #pill #maker #sues #FDA #preserve #access
    ( With inputs from : www.politico.com )

  • Minimal Access Heart Surgery Successfully Performed At Super Speciality Hospital

    [ad_1]

    SRINAGAR: A minimally invasive heart surgery was performed at the Super Specialty Hospital (SSH) in Jammu.

    Dr Shyam Singh, the Chief Surgeon at SSH, said that heart surgeries through small incisions have evolved over the years and become standardized. “These procedures need expertise and perseverance to make them a routine,” he said after carrying out a Heart Valve replacement procedure on a young female patient with Rheumatic Heart Disease from a far-off village called Chansri, Mughal Maidan Kishtwar.

    In this procedure, Dr Singh said, a small incision is made below the right breast to undertake the entire operation, and the fine scar hides in the breast crease and is cosmetic in female patients. The surgery requires less blood transfusion and less pain-relieving medication. The patient was able to move around in the ward the next morning, which is normally not possible in a conventional surgery, Dr Singh said.

    Furthermore, the patient had a rare blood group of O negative, and there was minimal blood loss during the procedure, according to Dr Singh.

    The surgical team included Dr Shyam Singh, Dr Ishtiyak Ahmed Mir, and Dr Arvind Kohli, while the anesthesia team was headed by Professor and HoD Cardiothoracic Anaesthesia Dr Puja Vimesh, who conducted the per-operative and postoperative management along with Dr Rasmeet Kour, Dr Vikas, Vikas Sharma, Arif, Sonal, and Abhiranjan. Charanjit Singh and Roshan Lal managed the vital parameters of the patient while the patient was on Heart lung machine during operation while theatre scrub sister Angmo helped to carry out the procedure.

    Principal GMC Jammu Professor Dr Shashi Sudan lauded the efforts of the Department of Cardiothoracic Surgery and Department of Cardiothoracic Anaesthesiology to make such surgeries possible and routine at SSH Jammu under the Ayushman Bharat Scheme, for which the Patients do not have to pay from their pockets. She further said that the Department of Cardiothoracic and Vascular Surgeons (CTVS) has been routinely doing open heart surgeries for the last two years, and very shortly Bypass surgeries (CABG) shall also be started, which shall be followed by starting Super-speciality DNB CTVS courses.

    Dr Sudan said that the department has already applied for DNB Vascular Surgery courses and is most likely to get permission soon. (KNO)

    [ad_2]
    #Minimal #Access #Heart #Surgery #Successfully #Performed #Super #Speciality #Hospital

    ( With inputs from : kashmirlife.net )

  • Alito keeps access to abortion pill unchanged for next five days while Supreme Court reviews emergency appeals

    Alito keeps access to abortion pill unchanged for next five days while Supreme Court reviews emergency appeals

    [ad_1]

    abortion pills 73837

    The appeals court ruling — if it takes effect — would suspend several policies the FDA has approved since 2016 to make mifepristone more accessible, including telemedicine prescription, mail delivery and retail pharmacy dispensing. The ruling also would suspend approval of the generic version of the drug and would narrow the window of time the drug can be prescribed from 10 to seven weeks of pregnancy — though off-label prescription after seven weeks would still be possible. The Biden administration warned the court in its Friday petition that letting these changes move forward would wreak “regulatory chaos” nationwide and harm patients.

    The ruling had been scheduled to take effect on Saturday. But it is now temporarily frozen by Alito’s interim orders — known as administrative stays — keeping everything on hold until next Wednesday night while the justices receive further briefing and decide whether to issue a longer stay.

    The anti-abortion medical groups challenging the pill’s approval have until noon on Tuesday to file responses. In a statement Friday, their attorney, Alliance Defending Freedom Senior Counsel Erin Hawley, called Alito’s stay orders “standard operating procedure” that would give justices “sufficient time to consider the parties’ arguments before ruling.”

    Alito’s move maintains for now the current national patchwork of abortion access, with near-total bans on all forms of abortion in many red states and broad access to both medication abortion and surgical abortion in blue states.

    Alito, a George W. Bush appointee who wrote the court’s decision last year overturning Roe v. Wade and allowing a wave of GOP-led states to impose abortion bans, single-handedly issued the administrative stays on Friday because all emergency appeals from the 5th Circuit are initially directed to him. As is customary with interim orders, he did not elaborate on why he granted the temporary relief. But administrative stays are typically intended only to buy the court time in fast-moving litigation and do not foreshadow the justices’ substantive views.

    The FDA did not immediately comment on the stay orders or how the agency plans to enforce the restrictions if the high court allows them to go into effect.

    Abortion rights groups cheered the stay orders and vowed to keep pressing the court to permanently halt the looming restrictions on the drug. Anti-abortion groups called them disappointing, with one group, Students for Life, accusing the Supreme Court of “playing politics.”

    The legal battle over mifepristone escalated last week when a federal district judge in Texas, Matthew Kacsmaryk, issued an order suspending the approval of mifepristone nationwide and halting the various moves FDA has made since 2016 to broaden access to the drug.

    On Wednesday, a panel of the New Orleans-based 5th Circuit issued a 2-1 ruling putting a hold on the portion of the lower judge’s order that suspended the drug’s approval but allowing the rest of his decision to kick in on Saturday.

    That prompted the Justice Department and Danco, which makes the brand-name version of mifepristone, to turn to the high court for relief. They said that even the 5th Circuit panel’s approach – leaving the drug approved but rolling back expanded access in recent years – would be highly disruptive and could force the company to stop selling and distributing the drug for months.

    Adding to the turmoil is a separate ruling from a federal judge in Washington state, who last week ordered the FDA not to permit any new restrictions on access to mifepristone in 17 states and the District of Columbia.

    [ad_2]
    #Alito #access #abortion #pill #unchanged #days #Supreme #Court #reviews #emergency #appeals
    ( With inputs from : www.politico.com )

  • A 21-year-old with top secret access? It’s not as rare as you think

    A 21-year-old with top secret access? It’s not as rare as you think

    [ad_1]

    ap23103742632332

    “We entrust our members with a lot of responsibility at a very early age. Think about a young combat platoon sergeant, the responsibility and trust we put into those individuals to lead troops in combat,” Pentagon spokesperson Brig. Gen. Patrick Ryder told reporters Thursday while declining to comment on the DOJ investigation. “You receive training and you will receive an understanding of the rules and requirements that come along with those responsibilities.”

    The FBI on Thursday arrested Jack Teixeira, a 21-year-old member of the Massachusetts Air National Guard, in connection with the major leak of dozens of pages of classified Pentagon documents, many of which were photos of slides developed by the Joint Staff to brief senior leaders about the situation in Ukraine.

    No specific charges were immediately announced, but Teixeira is expected to appear in federal court in Boston on Friday.

    Live video from local television stations showed law enforcement leading the young male suspect from his home in North Dighton, Massachusetts, where both Teixeira and his mother live.

    The Pentagon released Teixeira’s service record after the FBI arrest, saying he was with the 102nd Intelligence Support Squadron at Otis Air National Guard Base, Massachusetts. He enlisted in 2019, and works on cyber transport systems as a network manager, according to National Guard Bureau spokesperson Nahaku McFadden.

    Since news of the leak emerged last week, Pentagon leaders have been tightening the distribution of classified information. Defense Secretary Lloyd Austin has been convening daily meetings about the breach’s effect on national security and on how to manage military secrets, Ryder said.

    DoD officials are reviewing “a variety of factors” related to safeguarding classified material, and are taking steps such as updating distribution lists and assessing how and where intelligence is shared, Ryder added.

    “It’s important to understand that we do have stringent guidelines in place,” Ryder said. “This was a deliberate criminal act, a violation of those guidelines.”

    In a statement, Austin said he would “not hesitate to take any additional measures necessary to safeguard our nation’s secrets. He added that he has directed the department’s intelligence leaders to review “intelligence access, accountability and control procedures within the Department to inform our efforts to prevent this kind of incident from happening again.”

    Across the world, potentially hundreds or even thousands of people could have had access to the classified information in question, DoD officials said. The leak is prompting questions about whether too many people have exposure to the military’s most sensitive secrets.

    “Especially post-Manning and post-Snowden, one of the lessons learned across the military is the greater the number of people that have access to information at any given time, the greater the likelihood of this thing spilling,” said the first official, referring to former Army soldier Chelsea Manning — convicted in 2013 of leaking classified documents to WikiLeaks, and to Edward Snowden, a former contractor who leaked classified information on the National Security Agency.

    In most cases, a variety of information is available to an individual with a security clearance over and above what they need to do their jobs. Like Snowden, the person who leaked the documents had access to a number of sensitive documents, but the person was required to “self-police” what they actually accessed, Zaid said.

    “It is entirely possible he was tasked with creating briefing books or intel briefings for his command,” he said.

    After the arrest, lawmakers were quick to condemn the leak and call for a revision of the rules. Sen. Jack Reed (D-R.I.), chair of the Senate Armed Services Committee, called on the national security community to address “systematic issues,” including “protocols for how intelligence is handled, the security clearance process, and how officials can prevent intelligence leaks like this from ever happening again.”

    “This was a major security breach that cannot be allowed to happen again. Leaking this trove of classified information endangered our military and intelligence professionals and undermined the security of our allies and partners,” Reed said.

    “Anyone with a security clearance who betrays their country by purposefully mishandling classified documents or disclosing classified materials must be held accountable,” he added.

    In an interview, Rep. Seth Moulton (D-Mass.) said the issue of how military members handle classified information is “obviously something we’re gonna look at.”

    “But what I am more interested in is a sort of digital watermarking technology that could just make it very clear to anybody viewing intelligence that we know if you’re looking at this,” added Moulton, a former Marine. “If every one of the documents [the leaker] saw was essentially marked with his name in a decipherable way, then that would just be a huge deterrent to sharing intelligence in the future.”

    Moulton also noted the age of the suspect and broader issues of giving younger people access to such sensitive information.

    “Not to take anything away from the severity of this incident and the criminality of this individual, but this is in some ways related to a broader issue that the U.S. military is facing with recruiting young Americans who — through social media or whatever else — feel incredibly entitled.

    “I’ve seen this problem in other aspects of the military,” he continued. “This really is an issue that sort of seems to be a Gen Z issue where you get some of our youngest members of the military who feel particularly self important and entitled and therefore the rules don’t apply to them.”

    Lisa Kashinsky contributed to this report.

    [ad_2]
    #21yearold #top #secret #access #rare
    ( With inputs from : www.politico.com )

  • What last night’s abortion pill twist means for access — even in blue states

    What last night’s abortion pill twist means for access — even in blue states

    [ad_1]

    Unless the Supreme Court intervenes, the 5th Circuit’s decision means that starting Saturday, mifepristone will remain legal at the federal level but access will be much more restricted.

    Mifepristone, one of two drugs commonly used together to cause an abortion, was approved 23 years ago by the FDA for use in the first 10 weeks of pregnancy and recently became the most common method of abortion in the United States.

    The 5th Circuit did not go as far as U.S. District Court Judge Matthew Kacsmaryk, whose ruling last Friday would have effectively removed the pill from shelves nationwide, but it did significantly roll back much of the FDA’s recent efforts to expand access.

    The court decision cuts off — at least temporarily — many of the pathways patients have used to obtain the pill in the last few years, including telemedicine prescriptions and mail delivery, and moves the cutoff for prescriptions from the current 10 weeks of pregnancy to seven.

    Should the ruling stand, retail pharmacies will no longer be authorized to dispense the drug. Physicians will not be able to prescribe the drug via telemedicine; instead, patients will have to make multiple in-person office visits to get a prescription. Additionally, non-physicians will not be able to prescribe or administer the drug, and prescribers will have to resume reporting “non-fatal adverse events” related to mifepristone to the federal government. The decision also suspends FDA approval of the company GenBioPro’s generic version of mifepristone, another blow to access.

    Isn’t there another abortion pill?

    Yes, misoprostol. The two pills are usually taken together to end a pregnancy during the first 10 weeks. Numerous studies have found both pills to be safe and effective.

    The new restrictions set to take effect don’t apply to misoprostol, because it is subject to fewer FDA regulations as the medication is primarily prescribed for non-abortion purposes, including treatment for stomach ulcers. Misoprostol can still be used on its own to end a pregnancy and abortion providers around the country say they’ve been preparing for months to pivot to offering misoprostol-only abortions if needed. However, there is a slightly higher risk of side effects and complications when the pills are used without mifepristone. States including California and New York announced this week that they’d be stockpiling misoprostol as a way to ensure access to an alternative method of abortion.

    What does the Biden administration do now?

    Attorney General Merrick Garland said Thursday that the Justice Department will seek emergency relief from the Supreme Court in order “to defend the FDA’s scientific judgment and protect Americans’ access to safe and effective reproductive care.” It would take five justices to put the 5th Circuit’s decision on hold and maintain the status quo while further appeals continue, although it’s possible Justice Samuel Alito — who oversees the 5th Circuit — could issue a temporary stay while the other justices weigh in.

    Can doctors use “off label” prescribing beyond seven weeks of pregnancy?

    Yes, but they may be reluctant to do so. The 5th Circuit’s decision rolled back an FDA policy that had expanded the use of mifepristone for use in the first 10 weeks of pregnancy rather than just the first seven weeks. Many doctors currently prescribe the drug beyond 10 weeks as an off-label use. Under the court decision, prescribing the drug after seven weeks would now be considered off-label. Some doctors may exercise that option, but there is likely to be a chilling effect from the court’s decision, with many doctors wary of running afoul of the court order during a time of legal uncertainty.

    What does this mean for people who live in states where abortion is illegal after six weeks?

    Most people do not know they are pregnant before six weeks. Abortion pills, which could be ordered online and delivered through the mail, had been seen as a way for people who live in states with six-week bans to terminate their pregnancies even after six weeks. Reining in the drug’s availability is likely to dramatically diminish its usefulness in these states.

    What about in blue states, where most abortions remain legal?

    The decision could also hamper access in blue states that have sought to maintain access to the pills, making them harder to access both for their own residents and the wave of people traveling from red states to terminate a pregnancy.

    Jennifer Dalven, the director of the ACLU’s Reproductive Freedom Project, argued to reporters Thursday that a competing district court ruling out of Washington state ordering the FDA to maintain the status quo should mean that nothing changes in the 17 states and Washington, D.C., where attorneys general sued the FDA — but without clear direction from judges and administration officials the legal status in those states remains uncertain.

    “In some places, FDA is under an obligation, a court order, not to further restrict access to abortion,” she said. “But it is completely unclear right now exactly how this will play out. We really need guidance both from the Supreme Court and potentially, ultimately the FDA.”

    Even if those 17 states and D.C. are shielded from the impact of the ruling for now, several of the country’s biggest states, including New York and California, are not part of the case and thus could be hit with the new restrictions ordered by the 5th Circuit.

    What will the anti-abortion challengers do?

    Alliance Defending Freedom, which represents the anti-abortion medical groups seeking to block access to mifepristone, told reporters on a call Thursday that it has “no immediate plans” to appeal the 5th Circuit’s decision even though the panel did not give anti-abortion groups the total suspension of the pills’ approval the groups requested and won from Kacsmaryk last week.

    “For now, we’ve got a great victory in the fact that there are now three required doctor visits to make sure women are safe, and the FDA complies with the rule of law,” said Erin Hawley, ADF’s senior counsel in the case. Hawley added, however, that the plaintiffs will continue pushing to have the FDA’s original approval of mifepristone overturned.

    “We anticipate that we might be able to persuade the 5th Circuit on a fuller briefing that the 2000 ruling is in play,” she said, noting that the appeals court did not take issue with the core of their arguments that the FDA approved the pills without adequately studying their safety risks and only took issue with the timeliness of the challenge to a decision the agency made 23 years ago.

    Josh Gerstein contributed to this report.

    [ad_2]
    #nights #abortion #pill #twist #means #access #blue #states
    ( With inputs from : www.politico.com )